50 programs are launching from 11 plants in the US, Brazil, France, Poland and China combine to be $20.8 million of annualized sales For the full-year 2025, we expect to launch eighty [80] new programs of which seventy [70] have already been won Highlights: Harold Bevis, Chief Executive Officer of NN Inc. commented, "We are excited to announce another record year of new business wins in our targeted growth areas. We have delivered a second consecutive year of record- setting commercial results. We are targe ...

MENLO PARK, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients' lives, today reported select preliminary, unaudited financial highlights for the fourth quarter and full year ended December 31, 2024. Select Preliminary Financial Highlights Fourth quarter 2024 total revenue is expected to be in the range of ...

VANCOUVER, British Columbia, Jan. 14, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic derivative of lysergic acid diethylamide (“LSD”), announced that the USPTO has granted the BETR-001 composition of matter patent US publication number US2023/0219955 with expiry in 2042. BetterLife now has multiple layers of intellectual property protection for BET ...

Highlights Strong copper grades from maiden fall 2024 drill program at the Sting Copper Project, western Newfoundland VB24-001: 20.5m at 1.21% Cu including 5.0m at 2.22% Cu and 54.8m at 0.32% Cu*VB24-002: 78.0m at 0.24% Cu including 9.0m at 0.76% CuVB24-003: 0.50m at 2.85% Cu and 0.50m at 1.92% Cu and 31.1m at 0.27% CuVB24-004: 2.70m at 0.61% CuVB24-005: 22.85m at 0.20% Zn including 3.5m at 0.51% Zn and 0.50m at 1.24% Cu and 0.60% Zn and 1.05m at 1.13% Cu and 0.12% Zn and 5.25m at 0.57% Cu VANCOUVER, Britis ...

Estimated Ultimate Recovery (EUR) increase of 30% in Kruh Field Webinar Media Interactive Call will be Held on Tuesday, January 21 at 10AM Eastern Time JAKARTA, INDONESIA AND DANVILLE, CA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Indonesia Energy Corporation (NYSE American: INDO) ("IEC"), an oil and gas exploration and production company focused on Indonesia, today announced that IEC senior management will hold an investor update conference call on Tuesday, January 21 at 10:00 a.m. Eastern Time to provide an updat ...

Seasoned solar executive with more than 20 years of commercial experience AUSTIN, Texas, Jan. 14, 2025 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software, and engineering services, announced today that it has appointed solar industry veteran Kent James as Chief Commercial Officer for North America, effective January 6, 2025. Mr. James will spearhead FTC's North American commercial strategy and execution and will report directly to Yann Brandt, FTC's CE ...

COVID-19 Phase 2b study poised to initiate 10,000 participant portion of trial pending U.S. Food and Drug Administration (FDA) review of sentinel cohort 30-day safety data Norovirus program to proceed with Phase 1 study following scientific advisory board and FDA feedback; Trial to initiate the first half of 2025 with topline data expected as early as mid-2025 New avian influenza vaccine candidate being tested in preclinical studies SOUTH SAN FRANCISCO, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. ...

About Aurélien Marabelle, MD, PhD Aurélien Marabelle, MD, PhDÂ is a physician-scientist with expertise in oncology (MD) and immunology (PhD). His clinical practice is dedicated to early phase clinical trials of cancer immunotherapies within the Drug Development Department (DITEP) of Gustave Roussy Cancer Center in France. He leads a translational research laboratory (LRTI) within the INSERM U1015 with a focus on mechanisms of action of immune targeted therapies. He is also the director of the Clinical Inves ...

Forward-Looking Statements All statements other than statements of historical facts contained in this press release are "forward-looking statements,†which may often, but not always, be identified by the use of such words as "may,†"might,†"will,†"will likely result,†"would,†"should,†"estimate,†"plan,†"project,†"forecast,†"intend,†"expect,†"anticipate,†"believe,†"seek,†"continue,†"target†or the negative of such terms or other similar expressions. These statements involve known and unknown risks, uncerta ...

Progress in Athabasca Basin and Wyoming Projects Paves the Way for 2025 Exploration ActivitiesCALGARY, Alberta, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Global Uranium Corp. (CSE: GURN | OTC: GURFF | FRA: Q3J) (the “Company”) is pleased to provide a summary of its accomplishments throughout 2024 and an exploration outlook for 2025. The Company has advanced its flagship Northwest Athabasca Project option (“NWA Project”) in Saskatchewan and its uranium exploration projects in Wyoming, positioning itself for an activ ...